A Study About Antibody Levels and Biomarkers in the Blood in People With Late-onset Pompe Disease | MicrobiomeTrials← Back to trialsNCT06150820
A Study About Antibody Levels and Biomarkers in the Blood in People With Late-onset Pompe Disease
RecruitingNAINTERVENTIONAL
Trial Details
Start: 2024-02-01Est. Completion: 2027-06-30
Enrollment target: 119 participants Locations- Emory Clinic, Atlanta, Georgia, United States
- University of Kansas Medical Center, Kansas City, Kansas, United States
- University of Michigan, Ann Arbor, Michigan, United States
- Children's Hospitals and Clinics of Minnesota, Minneapolis, Minnesota, United States
- Hackensack University Medical Center, Hackensack, New Jersey, United States
- University of Cincinnati, Cincinnati, Ohio, United States
- University of Pennsylvania, Philadelphia, Pennsylvania, United States
- University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania, United States
- University of UTAH - PPDS, Salt Lake City, Utah, United States
- Lysosomal and Rare Diseases Research and Treatment Center, Inc., Fairfax, Virginia, United States
- AU61003, Adelaide, Australia
- AU61001, Herston, Australia
- BR55003, Flamengo, Brazil
- BR55002, Porto Alegre, Brazil
- BR55001, São Paulo, Brazil
- CN15003, Edmonton, Canada
- CA15001, Montreal, Canada
- FR33006, Angers, France
- FR33009, Garches, France
- FR33005, Lille, France
- FR33007, Limoges, France
- FR33002, Marseille, France
- FR33003, Nantes, France
- FR33004, Nice, France
- FR33001, Strasbourg, France
- DT49005, Bonn, Germany
- DT49004, Essen, Germany
- DT49003, Höchheim, Germany
- DT49006, Münster, Germany
- IT39002, Florence, Italy
- IT39005, Gussago, Italy
- IT39012, Messina, Italy
- IT39009, Milan, Italy
- IT39011, Milan, Italy
- IT39008, Pavia, Italy
- IT39006, Pisa, Italy
- IT39004, Roma, Italy
- IT39003, Udine, Italy
- National Center of Neurology and Psychiatry, Kodaira-Shi, Japan
- Tokyo Women's Medical University Hospital, Shinjuku-Ku, Japan
- ES34003, Albacete, Spain
- ES34004, Barcelona, Spain
- ES34009, Donostia / San Sebastian, Spain
- ES34007, L'Hospitalet de Llobregat, Spain
- ES34001, Madrid, Spain
- ES34005, Madrid, Spain
- ES34002, Valencia, Spain
- TW88601, Taipei, Taiwan
- TW88602, Taipei, Taiwan
- TW88603, Taoyuan City, Taiwan
- UK44003, Cambridge, United Kingdom
- UK44001, Newcastle upon Tyne, United Kingdom
- UK44004, Salford, United Kingdom
Other microbiome trials you might be interested in
Pompe Disease (Late-onset)Pompe Disease Late-OnsetLOPD
This is a single-arm, open-label, dose-escalation study to evaluate the safety, tolerability and efficacy of a single in…
Phoenix, United StatesEst. completion Sep 2028
Late-Onset Pompe Disease
Late-onset Pompe disease (LOPD) is an inherited metabolic disorder caused by deficiency of acid alpha-glucosidase (GAA).…
Seville, SpainCompleted Apr 16, 2025